This approval allows Lupin to market a generic equivalent of Merck Sharp & Dohme’s Isentress HD Tablets, 600 mg, which are used in HIV-1 treatment
Read More
NaMuscla is the first and only approved treatment in Europe for these rare neuromuscular disorders, which are characterised by the inability of muscles to relax after voluntary contractions, leading to muscle stiffness (myotonia)
Read More
Emtricitabine and Tenofovir Alafenamide Tablets are indicated for the treatment or prevention of HIV-1 infection in adults and children weighing at least 35 kg
Read More
